Cerebras Boosts IPO Price Range to $150-$160 Due to High Demand: Sources

• The revised price range of $150-$160 per share would raise roughly $4.8 billion, up from $3.5 billion under original terms, with orders exceeding 20 times available shares
• Cerebras competes with Nvidia by making specialized chips better suited for AI inference (model deployment) rather than training, capitalizing on the shift in AI lab priorities
• This is Cerebras' second IPO attempt after pulling a 2024 filing due to national security review of its G42 partnership, which provided over 80% of revenue in H1 2024

Cerebras IPO Summary

Key Development:

Cerebras Systems is raising its IPO price range to $150-$160 per share due to exceptional demand, up from a previously reported $125-$135 range. At the top of this new range, the AI chipmaker would raise approximately $4.8 billion, compared to $3.5 billion under original terms.

Market Response:

The offering has attracted orders exceeding 20 times the available shares, reflecting strong investor appetite for AI infrastructure plays. The IPO is scheduled to price as soon as Monday and would be the largest global IPO of 2026, according to Dealogic.

Company Profile:

Sunnyvale, California-based Cerebras manufactures specialized AI chips competing in a market dominated by Nvidia. The company's processors are particularly well-suited for AI inference—the computations enabling AI models to respond to user queries—as the industry shifts from model training to deployment.

Recent Developments:

This marks Cerebras' second IPO attempt after initially filing in 2024 but withdrawing due to national security concerns. The company's partnership with UAE-based G42, which generated over 80% of revenue in H1 2024, underwent scrutiny by U.S. authorities before receiving clearance. Since then, Cerebras has secured major customers including Amazon and OpenAI.

Market Context:

The IPO surge reflects broader AI adoption driving demand for high-performance chips, with semiconductors becoming a critical supply chain bottleneck.

Deal Structure:

The offering is led by Morgan Stanley, Citigroup, Barclays, and UBS Group. Shares will trade on the Nasdaq.